Brami, C., Bao, T., & Deng, G. (2016). Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review. Critical Reviews in Oncology/Hematology, 98, 325–334. 

DOI Link

Purpose

STUDY PURPOSE: To provide a review of best evidence for chemotherapy-induced peripheral neuropathy (CIPN) treatments

TYPE OF STUDY: Systematic review

Search Strategy

DATABASES USED: PubMed, Web of Science
 
INCLUSION CRITERIA: Randomized, controlled trials of integrative oncology modalities in CIPN prevention or treatment
 
EXCLUSION CRITERIA: Animal studies

Literature Evaluated

TOTAL REFERENCES RETRIEVED: 1,465
 
EVALUATION METHOD AND COMMENTS ON LITERATURE USED: Not stated

Sample Characteristics

  • FINAL NUMBER STUDIES INCLUDED = 13 
  • TOTAL PATIENTS INCLUDED IN REVIEW = 685
  • SAMPLE RANGE ACROSS STUDIES: 16–201

Phase of Care and Clinical Applications

PHASE OF CARE: Active antitumor treatment

Results

Interventions included were vitamin E, glutamine, goshajinkigan, alpha-lipoic acid, omega-3 fatty acids, acupuncture, massage therapy, acetyl L carnitine, and physical activity. All interventions showed mixed findings, with findings suggesting that acetyl L carnitine may worsen symptoms in patients receiving chemotherapy.

Conclusions

Limited evidence exists to show the effectiveness of integrative therapies for the prevention or treatment of CIPN.

Limitations

  • Limited number of studies included
  • No quality evaluation
  • Low sample sizes

Nursing Implications

Very limited evidence exists for effective interventions to prevent or manage CIPN. More research is needed in this area.

Legacy ID

6499